MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1006326513176
Reference41 articles.
1. Cody HS: The impact of mammography in 1096 consecutive patients with breast cancer, 1979- 1993. Equal value for patients younger and older than 50 years. Cancer 76: 1579–1584, 1995
2. Valero V, Buzdar A, Hortobagyi G: Locally advanced breast cancer. Oncologist 1: 8–17, 1996
3. Mouridsen HT, Rose C, Brincker H: Adjuvant systemic therapy in high-risk breast cancer. The Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients. In: Senn HJ, (ed) Recent Results in Cancer Research, Adjuvant Chemotherapy of Breast Cancer. Heidelberg, Springer, 1984
4. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr: Extracellular matrix; Role of matrix metalloproteinase in tumour invasion and metastasis. FASEB J 7: 1434–1441, 1993
5. Höyhtyä M, Fridman R, Komareck D, Porter-Jordan K, StetlerStevenson WG, Liotta LA, Liang C-M: Immunohistochemical localization of matrix metailoproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissue with monoclonal antibodies. Int J Cancer 54: 500–505, 1994
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The angiogenic role of the alpha 9-nicotinic acetylcholine receptor in triple-negative breast cancers;Angiogenesis;2024-08-23
2. PATTERN OF MMP2 AND MMP9 EXPRESSION DEPENDS ON BREAST CANCER PATIENTS’ AGE;Experimental Oncology;2023-06-26
3. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis;BMC Cancer;2021-02-10
4. Tissue inhibitor of matrix metalloproteinase-3 has both anti-metastatic and anti-tumourigenic properties;Clinical & Experimental Metastasis;2020-01-01
5. Visualization of MMP-2 Activity Using Dual-Probe Nanoparticles to Detect Potential Metastatic Cancer Cells;Nanomaterials;2018-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3